Skip to main content
SpringerLink
Log in

Calcium channel blockers may have a role in organ transplantation

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weir MR, Suthanthiran M. Supplementation of immunosuppressive regimens with calcium channel blockers: rationale and clinical efficacy. Clin Immunother 1994; 2: 458–67

    Article  Google Scholar 

  2. van der Schaaf MR, Hené RJ, Floor M, et al. Hypertension after renal transplantation: calcium channel or converting enzyme blockade? Hypertension 1995; 25: 77–81

    Article  PubMed  Google Scholar 

  3. Toupance O, Lavaud S, Canivet E, et al. Antihypertensive effect of amlodipine and lack of interference with cyclosporine metabolism in renal transplant recipients. Hypertension 1994; 24: 297–300

    Article  PubMed  CAS  Google Scholar 

  4. Mourad G, Ribstein J, Mimran A. Converting-enzyme inhibitor versus calcium antagonist in cylcosporine-treated renal transplants. Kidney Int 1993; 43: 419–25

    Article  PubMed  CAS  Google Scholar 

  5. Van den Dorpel MA, Zietse R, Ijzermans JNM, et al. Effect of isradipine on cyclosporin A-related hypertension. Blood Press 1994; 3 Suppl. 1: 50–3

    Google Scholar 

  6. Ladefoged L, Anderson CB. Calcium channel blockers in kidney transplantation. Clin Transplantation 1994; 8: 128–33

    CAS  Google Scholar 

  7. Nyberg G, Haljamäe U, Herlitz H, et al. Early graft function in recipients treated with the calcium channel blocker felodipine. Scan J Urol Nephrol 1994; 28: 17–20

    Article  CAS  Google Scholar 

  8. Dawidson I, Ar’Rajab A, Dickerman R, et al. Perioperative albumin and verapamil improve early outcome after cadaver renal transplantation. Transplant Proc 1994; 26: 3100–1

    PubMed  CAS  Google Scholar 

  9. Wilkie ME, Beer JC, Evans SJW, et al. A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft function. Nephrol Dial Transplant 1994; 9: 800–4

    PubMed  CAS  Google Scholar 

  10. Morales JM, Rodriguez-Paternina E, Araque A, et al. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study. Transplant Proc 1994; 26: 2598–9

    PubMed  CAS  Google Scholar 

  11. Suthanthiran M, Haschemeyer RH, Riggio RR, et al. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. Transplantation 1993; 55: 1008–13

    Article  PubMed  CAS  Google Scholar 

  12. Aswad S, Devera-Sales A, Zapanta R. Costs for successful vs failed kidney transplantation: a two-year follow-up. Transplantation Proceedings 1993; 25: 3069–70

    PubMed  CAS  Google Scholar 

  13. Smith CL, Hampton EM, Pederson JA, et al. Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients. Pharmacotherapy 1994; 14: 471–81

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calcium channel blockers may have a role in organ transplantation. Drugs Ther. Perspect 5, 7–9 (1995). https://doi.org/10.2165/00042310-199505070-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505070-00003

Keywords

Search

Navigation